Examination of COVID stress syndrome facets and relations to substance misuse using profile analysis via multidimensional scaling (PAMS)
Journal of Affective Disorders · 2024
DOI: 10.1016/j.jad.2024.06.044 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Affective Disorders, 2024. Verfasst von Samuel D Spencer und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychology, University of North Texas, Denton, TX, USA; Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, H…. Hauptthemen laut MEDLINE: COVID-19, Substance-Related Disorders. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Canadian Institutes of Health Research.
Abstract (Originalsprache)
The COVID-19 pandemic has contributed to significant societal challenges, including increased substance misuse. The COVID stress syndrome is a constellation of interrelated processes that occur in response to pandemics, including danger/contamination fears, fears concerning economic consequences, xenophobia, compulsive checking/reassurance-seeking, and pandemic-related traumatic stress symptoms. In the present study, using a sample of 812 adults collected during the early stages of the COVID-19 pandemic in May 2020, we examined the relations between identified profiles of the COVID Stress Scales (CSS) and behavioral and cognitive aspects of substance misuse. Using profile analysis via multidimensional scaling (PAMS), we identified two core profiles of the CSS, which explained 60 % of the variance in participant responding: 1) High compulsive checking & Low xenophobia and 2) High xenophobia & Low danger/contamination. The first profile is consistent with the COVID stress syndrome, while the second profile aligns with the COVID disregard syndrome, which is a constellation of interrelated processes distinguished by a denial or downplaying of the seriousness of the COVID-19 pandemic and lack of perceived vulnerability to disease. Both profiles demonstrated significant positive correlations with drug and alcohol misuse, respectively. However, only the High xenophobia & Low danger/contamination profile demonstrated relations with cognitive aspects of substance misuse via positive and negative correlations with positive and negative expectancies of alcohol use, respectively. These findings provide further support for the relationship between the COVID stress syndrome and substance misuse and offer insight into how unique profiles of this syndrome may impact pandemic-related mental and public health interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychology, University of North Texas, Denton, TX, USA; Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, TX, USA. Electronic address: spence21@gmail.com.
- Psychology Division, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
- Department of Psychology, Fordham University, Bronx, NY, TX, USA.
- Department of Psychology, University of Regina, Regina, SK, Canada.
Förderung
- Canadian Institutes of Health Research
Zitieren
APA
Spencer, S. D., Kim, S. K., McKay, D., & Asmundson, G. J. G. (2024). Examination of COVID stress syndrome facets and relations to substance misuse using profile analysis via multidimensional scaling (PAMS). Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2024.06.044
Vancouver
Spencer SD, Kim SK, McKay D, Asmundson GJG. Examination of COVID stress syndrome facets and relations to substance misuse using profile analysis via multidimensional scaling (PAMS). Journal of Affective Disorders. 2024. doi:10.1016/j.jad.2024.06.044
BibTeX
@article{Spencer2024,
author = {Spencer, Samuel D and Kim, Se-Kang and McKay, Dean and Asmundson, Gordon J G},
title = {Examination of COVID stress syndrome facets and relations to substance misuse using profile analysis via multidimensional scaling (PAMS)},
journal = {Journal of Affective Disorders},
year = {2024},
doi = {10.1016/j.jad.2024.06.044}
}
EUVIMED